Skip to main content
. 2015 Aug 5;12:24. doi: 10.1186/s12981-015-0065-8

Table 3.

Comparison of blood pressure, plasma glucose and insulin concentrations and markers of insulin sensitivity and beta cell function at baseline and follow-up (n = 103)

Baseline median (IQR) Follow-up median (IQR) P-value*
Blood Pressure
 Systolic 111 (101–121) 121 (112–133) <0.001
 Diastolic 72 (64–80) 80 (73–89) <0.001
Glucose
 Fasting 5.1 (4.7–5.4) 4.9 (4.7–5.3) 0.365
 30 min 6.6 (5.8–7.4) 6.8 (5.9–8.0) 0.040
 120 min 5.4 (4.9–6.3) 5.6 (4.7–6.8) 0.028
Insulin
 Fasting 5.6 (3.3–9.5) 7.9 (4.1–12.9) 0.009
 30 min 35.1 (19.2–66.7) 177.7 (163.4–192.5) <0.001
 120 min 24.0 (13.5–40.2) 23.7 (10.4–54.9) 0.993
Glycaemic parameters (without diabetics and outliers)
 HOMA-IRa 1.2 (0.7–2.2) 1.6 (0.9–2.7) 0.089
 IGIb 23.7 (11.9–33.1) 80.0 (54.0–137.4) <0.001
 DIco 3.5 (2.3–7.9) 11.9 (4.9–23.3) <0.001

* Non-parametric paired t-test.

aHOMA-IR = (fasting glucose × fasting insulin)/22.5.

bIGI = ΔInsulin0-30/ΔGlucose0-30.

cDIo [Oral disposition index] = (ΔInsulin0-30/ΔGlucose0-30) × (1/fasting insulin).